AGMB - Latest News
AgomAb Therapeutics N.V. American Depositary Shares (AGMB), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $554.0M. Beta to the broader market is 0.00.
The article list below shows the most recent AGMB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent AGMB Headlines
Agomab Announces Results of Annual General Meeting
globenewswire.com - May 27, 2026
Antwerp, Belgium, May 27, 2026 - Agomab Therapeutics NV (Nasdaq: AGMB) ("Agomab"), a clinical-stage biopharmaceutical company focused on fibro-inflamm
Agomab Announces Results of Annual General Meeting
globenewswire.com - May 27, 2026
Antwerp, Belgium, May 27, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflamm
Agomab to Participate in Upcoming Conferences
globenewswire.com - May 14, 2026
Antwerp, Belgium, May 14, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflamm
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook
globenewswire.com - Apr 23, 2026
-- Cash and Cash Investments at December 31, 2025 of €116. 5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) Expected t
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook
globenewswire.com - Apr 23, 2026
-- Cash and Cash Investments at December 31, 2025 of €116. 5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) Expected to
How News Affects AGMB Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AGMB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked AGMB news questions
- What is the latest AGMB news headline?
- The most recent AGMB headline (May 27, 2026) is "Agomab Announces Results of Annual General Meeting". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the AGMB news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What AGMB news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual AGMB options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.